UE LifeSciences Inc.

UE LifeSciences Inc. is a medical device innovator focused on accessible, hand-held diagnostic solutions for early cancer detection in resource-limited and low-income settings. The company develops non-invasive, radiation-free, pain-free screening devices operable by community health workers with minimal training and offline capability, enabling instant results with validated high efficacy. Their product portfolio addresses breast, cervical, and oral cancer screening—the leading cancer burdens in underserved populations globally. iBreastExam is an extensively validated handheld breast lump detection device; cervAIcal is a mobile colposcope for cervical cancer assessment; OrCA addresses oral cancer screening. RaKSA is a multi-cancer screening navigation initiative integrating breast, cervical, and oral examination into single-visit protocols for large-scale implementation. The company has supplied over 2 million breast exams, detected 500+ cancers, and operates in 10 markets across USA, India, Malaysia, Colombia, and Thailand. UE LifeSciences partners with HLL Lifecare (India), major imaging-diagnostics firms, and regional pharma and diagnostics distributors. The company has raised $8.5M in capital, secured $1.7M+ in grants, and earned 15+ awards. Featured in The New York Times, BBC News, Forbes, and TED Talks, UE LifeSciences targets primary and secondary care providers, government health programs, NGOs, and private healthcare networks seeking equitable early detection infrastructure.